Israeli - Kiebrania - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

Israeli - Kiebrania - Ministry of Health

ferring pharmaceuticals ltd - atosiban - solution for injection - atosiban 7.5 mg/ml - atosiban - atosiban - atosiban is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes - a cervical dilation of 1 to 3 cm (0-3 for iparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate.

Israeli - Kiebrania - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Israeli - Kiebrania - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Israeli - Kiebrania - Ministry of Health

teva pharmaceutical industries ltd, israel - epinephrine - תמיסה להזרקה - epinephrine 1 mg/ml - epinephrine - epinephrine - relief of respiratory distress due to bronchospasm. rapid relief of hypersensitivity reaction to drugs and other allergens.prolongation of the action of infiltration anesthetics. adrenaline may be of value in restoring cardiac rhythm in cardiac arrest.however it is not used in cardiac failure or in hemorrhagic traumatic or cardiogenic shock. treatment of mucosal congestion of hay fever rhinitis and acute sinusitis.relief of bronchial asthmatic paroxysms. symptomatic relief of serum sickness urticaria and angioneurotic edema.open-angle glaucoma. relaxation of uterine musculature and inhibition of uterine contractions. hemostatic agent in syncope due to complete heart block or carotid sinus hypersensitivity and for resuscitation in cardiac arrest following anesthetic accidents.

Israeli - Kiebrania - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 500 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

Israeli - Kiebrania - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 750 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

Israeli - Kiebrania - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 1000 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

Israeli - Kiebrania - Ministry of Health

איתיו ביוטי - עיצוב השיער

Israeli - Kiebrania - Ministry of Health

איתיו ביוטי - עיצוב השיער